sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes

$657,203

Kristen M Pogreba-Brown · University Of Arizona · R01 · FY2025 · DK

AMPK Regulation of ACE2 in Endothelial Health and Disease

$656,945

John Y-J Shyy · University Of California, San Diego · R01 · FY2025 · HL

Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses

$656,804

Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2024 · AI

Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses

$656,497

Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2023 · AI

Monoclonal Antibody to Combat Pseudomonas Aeruginosa

$656,358

Joanna B. Goldberg · Emory University · R01 · FY2025 · AI

Improving the Collaborative Health of Minority COVID-19 Survivor & Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities

$656,333

Gayenell Smith Magwood · University Of South Carolina At Columbia · R01 · FY2023 · NR

Pain Relief with Integrative Medicine (PRIMEe)?: Feasibility Trial of Acupuncture for Long COVID

$656,157

Nikki Gentile · University Of Washington · R34 · FY2024 · AT

Olfactory and neurological manifestations of acute and post-acute murine COVID-19

$656,039

Stanley Perlman · University Of Iowa · R01 · FY2024 · AI

Micro Analytical Immunochemistry

$655,495

Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2022 · EB

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)

$655,464

Michael David Hughes · Harvard School Of Public Health · UM1 · FY2020 · AI

In vivo PET imaging of novel engineered AAVs informs capsid design

$655,422

Katherine W Ferrara · Stanford University · R01 · FY2020 · EB

Emory Vaccine and Treatment Evaluation Unit - DMID 21-0002

$655,337

Nadine Georges Rouphael · Emory University · UM1 · FY2021 · AI

Automated, optimized, intelligent data collection for cryo-EM

$655,046

Gabriel C Lander · Scripps Research Institute, The · R01 · FY2021 · GM

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

$654,367

Vikram S Chib · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2025 · NS

COVID-19 and Acute Medical Care: Impact on Dementia Patients

$654,203

John Hsu · Massachusetts General Hospital · R01 · FY2020 · AG

Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection

$654,116

Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2020 · AI

Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction

$653,547

Lora Bankova · Brigham And Women'S Hospital · R01 · FY2024 · DC

Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility

$653,509

Sanjana Dayal · University Of Iowa · R01 · FY2025 · AI

Olfactory mucosa repair and defense: neuro-immune mechanisms and therapy

$653,305

Andrew P Lane · Johns Hopkins University · R01 · FY2024 · DC

Chemically Modified Peptide Nucleic Acids

$653,285

Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Chemically Modified Peptide Nucleic Acids

$653,285

Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

Discovery of SARS-CoV-2 antivirals using a replicon assay

An Intrinsic Link between the Metabolic and Antiviral States of the Cell

DEVELOPMENT OF A VIDEO-BASED PERSONAL PROTECTIVE EQUIPMENT MONITORING SYSTEM

Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes

AMPK Regulation of ACE2 in Endothelial Health and Disease

Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses

Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses

Monoclonal Antibody to Combat Pseudomonas Aeruginosa

Improving the Collaborative Health of Minority COVID-19 Survivor & Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities

Pain Relief with Integrative Medicine (PRIMEe)?: Feasibility Trial of Acupuncture for Long COVID

Olfactory and neurological manifestations of acute and post-acute murine COVID-19

Micro Analytical Immunochemistry

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)

In vivo PET imaging of novel engineered AAVs informs capsid design

Emory Vaccine and Treatment Evaluation Unit - DMID 21-0002

Automated, optimized, intelligent data collection for cryo-EM

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

COVID-19 and Acute Medical Care: Impact on Dementia Patients

Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection

Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction

Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility

Olfactory mucosa repair and defense: neuro-immune mechanisms and therapy

Chemically Modified Peptide Nucleic Acids

Chemically Modified Peptide Nucleic Acids